/People

Greg Yap

Investor

Partner at Menlo Ventures · Board director at Cartwheel · Board director at Koala Health · Board director at H1 Insights

Bay Area

Writes $250K – $15M checks · typically $12M

Find your path to Greg

161 people in our graph can introduce you to Greg.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Helen Siaw to introduce you to Greg

You →Helen · together at Epiodyne (2023–2024) →Greg

Ask Jamie Chen to introduce you to Greg

You →Jamie · 2 people · together at Ophelia →Greg

Ask Sam Okafor to introduce you to Greg

You →Sam · together at Cartwheel →Greg

Sign up to find every way you can get introduced to Greg

  • Your email: the people you already email who know Greg
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Greg
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Partner at Menlo Ventures since 2017 investing in life science and healthcare, including therapeutic platforms, digital health, and transformative technologies. Previously an entrepreneur-in-residence at Illumina Ventures and GE, and a two-time startup CEO/co-founder (BlueLight Therapeutics and PyrAmes) with two decades of life-science operating experience at Roche/Ventana, Cellpoint, and Affymetrix.

Likely email· guessed from name + firm domain, not firm-published

Invests in

AI & Machine LearningBiotechCybersecurityDigital HealthFintechHealthtechMedical Devices

Board director at Cartwheel

Intro paths

→

In turn, Greg can intro founders to Cartwheel's investors below.

Co-founders at Cartwheel

JEJoe English
Joe EnglishCo-Founder and CEO

Board director at Koala Health

Intro paths

→

In turn, Greg can intro founders to Koala Health's investors below.

Co-founders at Koala Health

GC
Gavin CotterExecutive Officer, Director

Board director at H1 Insights

Intro paths

→

In turn, Greg can intro founders to H1 Insights's investors below.

Co-founders at H1 Insights

AKAriel Katz
Ariel KatzExecutive Officer, Director
IS
Ian SaxExecutive Officer, Director

Experience

  1. Menlo VenturesPartnercurrent2017 — presentSan Francisco Bay Area
  2. The Aspen InstituteHealth Innovators Fellowcurrent2019 — present
  3. Aurora TherapeuticsBoard Member & Investorcurrent2025 — present
  4. Chai DiscoveryBoard Member & Investorcurrent2025 — present
  5. Colla HealthBoard Member & Investorcurrent2024 — present
  6. Xaira TherapeuticsInvestorcurrent2024 — present
  7. CartwheelBoard Member & Investorcurrent2023 — present
  8. VilyaBoard Observer & Investorcurrent2023 — present
  9. Koala HealthBoard Member & Investorcurrent2022 — present
  10. OpheliaBoard Member & Investorcurrent2021 — present
  11. Scribe TherapeuticsInvestorcurrent2021 — present
  12. Genesis TherapeuticsBoard Observer & Investorcurrent2020 — present
  13. H1Board Member & Investorcurrent2020 — present
  14. Particle HealthBoard Member & Investorcurrent2020 — present
  15. Delfi DiagnosticsBoard Member & Investorcurrent2019 — present
  16. Riva HealthBoard Member & Investorcurrent2019 — present
  17. Encoded Therapeutics Inc.Investorcurrent2019 — present
  18. BenchlingInvestorcurrent2019 — present
  19. Clear LabsBoard Member & Investorcurrent2019 — present
  20. EpiodyneBoard Member & Investorcurrent2018 — present

Skills & more

Assay Development23DNA17Molecular Diagnostics40Biotechnology53Lifesciences20Genomics71Commercialization70Oncology20Medical Devices30Molecular Biology20Strategy24Medical Diagnostics4
+8 moreHardware DiagnosticsProduct DevelopmentImmunologyCross-functional Team LeadershipPersonalized MedicineGlobal MarketingBusiness DevelopmentProduct Management

From Greg's professional profile.

Deals · 5

Delfi DiagnosticsBoard seat

via Menlo Ventures · filed Dec 2025 · $60M raise

Koala HealthBoard seat

via Menlo Ventures · filed Dec 2022 · $20M raise

Vital LabsBoard seat

via Menlo Ventures · filed Sep 2022 · $8M raise

OpheliaBoard seat

via Menlo Ventures · filed Apr 2021 · $15M raise

H1 InsightsBoard seat

via Menlo Ventures · filed Dec 2020 · $58M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: the firm's website · SEC Form D filings · curated public sources.

Colleagues at Menlo Ventures

Network4

Investors connected to Greg in public investor directories — a warm-intro map.

Frequently asked questions

Who is Greg Yap?
Partner at Menlo Ventures since 2017 investing in life science and healthcare, including therapeutic platforms, digital health, and transformative technologies. Previously an entrepreneur-in-residence at Illumina Ventures and GE, and a two-time startup CEO/co-founder (BlueLight Therapeutics and PyrAmes) with two decades of life-science operating experience at Roche/Ventana, Cellpoint, and Affymetrix.
Where does Greg Yap work?
Greg Yap is Partner at Menlo Ventures and Board director at Cartwheel and Board director at Koala Health and Board director at H1 Insights.
What does Greg Yap invest in?
Greg Yap invests in AI & Machine Learning, Biotech, Cybersecurity, Digital Health, Fintech, Healthtech, Medical Devices.
What check size does Greg Yap write?
Greg Yap typically writes checks of $250K – $15M.
What boards does Greg Yap sit on?
Greg Yap holds tracked board seats at Cartwheel, Clear Labs, Delfi Diagnostics, H1 Insights, Koala Health, Ophelia, Particle Health, Vital Labs.
What companies has Greg Yap invested in?
Investments tracked here include Cartwheel, Clear Labs, Curie, Delfi, Encoded, Epiodyne, Genesis, H1, Koala, Ophelia, Particle, Pliant (PLRX), and 27 more.
Where did Greg Yap go to school?
Greg Yap studied at Stanford University (MBA); Princeton University (AB, Molecular Biology).
Does Greg Yap lead rounds?
Yes — Greg Yap has led 16 tracked investments.

Same school

Shared employers